Privium Fund Management B.V.
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 1795097
AMSTERDAM, P7
Position in RARE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$11,312,532
+$3,669,931 QoQ
Shares Held
338,800
-7.1% QoQ
Ownership
0.344%
of shares outstanding
% of Portfolio
2.08%
of 13F equity value
Holder Rank
#53
of 310 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Privium Fund Management B.V. holds $162,489,015 across 32 Biotechnology names. RARE ranks #4 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
319,924 | $25,366,773 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
234,222 | $19,091,435 | |
| 3 | QURE |
uniQure N.V.
|
328,322 | $15,122,511 | |
| 4 | RARE |
Ultragenyx Pharmaceutical Inc.
This page
|
338,800 | $11,312,532 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
399,367 | $10,471,402 | |
| 6 | PRQR |
ProQR Therapeutics N.V.
|
5,520,024 | $10,267,244 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
39,944 | $9,777,092 | |
| 8 | URGN |
UroGen Pharma Ltd.
|
210,000 | $7,728,000 |
All Filings in RARE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,312,532 | 338,800 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $7,642,601 | 364,802 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $8,222,546 | 357,502 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $8,717,304 | 289,804 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $9,210,133 | 253,304 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $9,045,402 | 249,804 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $10,870,046 | 258,380 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $13,471,541 | 242,512 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $10,340,842 | 251,602 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $10,043,112 | 215,102 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $7,962,316 | 166,506 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $4,108,341 | 115,241 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $5,177,677 | 112,241 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $4,440,714 | 110,741 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $4,945,310 | 106,741 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $3,409,740 | 82,341 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $6,258,274 | 104,899 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $8,186,234 | 112,727 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $8,562,968 | 101,831 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||